Not Yet RecruitingPhase 1ACTRN12623001092684

Safety and feasibility of Poly Aryl Ether Ketone (PAEK) Implant for Contour Restoration in Jaw Reconstruction. A Pilot Trial


Sponsor

Chris O'Brien Lifehouse

Enrollment

12 participants

Start Date

Jul 1, 2024

Study Type

Interventional

Conditions

Summary

This study aims to assess the safety and feasibility of Poly Aryl Ether Ketone (PAEK) Implant for Contour Restoration in Jaw Reconstruction in patients with (or without) head and neck cancer Who is it for? You may be eligible to join this study if you are aged 18 years and older, have head and neck cancer and will undergo jaw reconstruction Study details All participants in this study will have a jaw reconstruction using a Poly Aryl Ether Ketone (PAEK) contouring implant. Participants will have two appointments with the reconstructive surgeon prior to the reconstruction to get 3D optical facial scans and CT scans of the facial bones and fibula and intraoral scan of dentition (teeth). The PAEK contouring implant will be manufactured to match participant’s jaw contour using computer aided design and computer aided manufacturing. The PAEK will then be implanted permanently during the jaw reconstruction. Participants will be followed-up post-operatively for 12 months to assess safety, integration of implantation and quality of life in participants. It is hoped that this research project will improve the aesthetics of patients undergoing jaw reconstruction.


Eligibility

Sex: Both males and femalesMin Age: 18 Yearss

Inclusion Criteria4

  • years and older
  • Head and neck cancer
  • Undergoing fibula free flap reconstruction of the mandible where there is a > 10 mm deficit in the mandible contour that would normally (without the PAEK implant) result in asymmetry
  • Willingness to give informed consent

Exclusion Criteria8

  • Active soft tissue infection or osteomyelitis
  • Less than 18 years of age
  • Previously undergone renal or any other allogeneic transplantation and on high dose immunosuppressive therapy
  • Unable to give informed medical consent due to cognitive impairment of psychiatric illness
  • Current or recent drug and/or alcohol abusers
  • On high dose immunosuppressive therapy including high dose steroids and methotrexate
  • A history of an endocrine, connective tissue, or metabolic disorder known to severely affect osteogenesis (e.g., Paget’s Disease, renal osteodystrophy, Ehlers- Danlos Syndrome, or osteogenesis imperfecta)
  • On other clinical trials who have received treatment with an investigational therapy within 28 days prior to reconstructive surgery or where treatment is planned during or after the follow up period

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

The use of Poly Aryl Ether Ketone (PAEK) contouring implant will be offered to participants who are undergoing fibula free flap reconstruction of the mandible where there is a > 10 mm deficit in the m

The use of Poly Aryl Ether Ketone (PAEK) contouring implant will be offered to participants who are undergoing fibula free flap reconstruction of the mandible where there is a > 10 mm deficit in the mandible contour that would normally (without the PAEK implant) result in asymmetry. PAEK contouring implant will be manufactured to match participant’s jaw contour using computer aided design and computer aided manufacturing. Participants will be asked to participate in the following interventions: Intervention • Appointment 1 (4 - 8 weeks prior to Baseline visit and Approximately 1 hour duration): - Informed consent - Medical History and Clinical History - Administration of quality of life questionnaire (Face Q) - 3D optical facial scan - CT scans of facial bones and fibula and intraoral scan of dentition as per standard of care. • Appointment 2 (Baseline 8-10 hours and Approximately additional 30-45 minutes duration during the standard fibula free flap reconstruction of the mandible): - Permanent implantation of PAEK contouring implant during fibula free flap reconstruction of the mandible - Participants will have PAEK contouring implant permanently - The surgical procedures will be exactly the same as a standard fibula flap reconstruction with only addition of fixation of the PAEK implant with titanium screws to the residual mandible and fibula flap. Follow up • Daily post operatively during participant's hospital admission (Approximately 15 minutes duration): - Assessment of treatment related adverse event • Day 14 post operation (Approximately 15 minutes duration): - Assessment of treatment related adverse event • Day 28 post operation (Approximately 15 minutes duration): - Assessment of treatment related adverse event • 3 months (Approximately 30 minutes duration): - Assessment of treatment related adverse event - Administration of quality of life questionnaire (Face Q) - 3D optical facial scan - CT scans of facial bones (standard of care) • 6 months (Approximately 30 minutes duration): - Assessment of treatment related adverse event - Administration of quality of life questionnaire (Face Q) - 3D optical facial scan - CT scans of facial bones (Standard of care) • At 12 months and then 12 monthly for 5 years (Approximately 30 minutes duration): - Assessment of treatment related adverse event - Administration of quality of life questionnaire (Face Q) - 3D optical facial scan - CT scans of facial bones (Standard of care) Intervention will be delivered face to face in the hospital clinic/operative theatre by a qualified reconstructive surgeon. There is no requirement for assessment of adherence. The design of PAEK contouring implant will conducted under a specific protocol to maintain the fidelity of intervention.


Locations(1)

Chris O’Brien Lifehouse - Camperdown

NSW, Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12623001092684